These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37453153)

  • 1. Secretory leukocyte protease inhibitor modulates FcεRI-dependent but not Mrgprb2-dependent mastocyte function in psoriasis.
    Kwiecinska P; Kwitniewski M; Kwiecien K; Morytko A; Majewski P; Pocalun N; Pastuszczak M; Migaczewski M; Cichy J; Grygier B
    Int Immunopharmacol; 2023 Sep; 122():110631. PubMed ID: 37453153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.
    Kwiecinska P; Grygier B; Morytko A; Sanecka-Duin A; Majchrzak-Gorecka M; Kwitniewski M; Kapinska-Mrowiecka M; Porebski G; Cichy J
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1266-1274. PubMed ID: 35279880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
    Westin U; Polling A; Ljungkrantz I; Ohlsson K
    Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histamine release from human mast cells by natural chymase inhibitors.
    He SH; Xie H; Zhang XJ; Wang XJ
    Acta Pharmacol Sin; 2004 Jun; 25(6):822-6. PubMed ID: 15169639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.
    Zabieglo K; Majewski P; Majchrzak-Gorecka M; Wlodarczyk A; Grygier B; Zegar A; Kapinska-Mrowiecka M; Naskalska A; Pyrc K; Dubin A; Wahl SM; Cichy J
    J Leukoc Biol; 2015 Jul; 98(1):99-106. PubMed ID: 25917460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
    Adhikari N; Shim WS
    Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis.
    Murata E; Sharmin S; Shiota H; Shiota M; Yano M; Kido H
    Curr Eye Res; 2003 May; 26(5):271-6. PubMed ID: 12854054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
    Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
    Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.
    Sullivan AL; Dafforn T; Hiemstra PS; Stockley RA
    Respir Res; 2008 Aug; 9(1):60. PubMed ID: 18699987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
    Thapaliya M; Ali H
    Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
    Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
    Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
    Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
    Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leukocyte proteinase inhibitor-competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis.
    Skrzeczynska-Moncznik J; Wlodarczyk A; Zabieglo K; Kapinska-Mrowiecka M; Marewicz E; Dubin A; Potempa J; Cichy J
    J Immunol; 2012 Aug; 189(4):1611-7. PubMed ID: 22786767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
    Yang J; Zhu J; Sun D; Ding A
    Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
    Westin U; Lundberg E; Wihl JA; Ohlsson K
    Allergy; 1999 Aug; 54(8):857-64. PubMed ID: 10485390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of secretory leukocyte peptidase inhibitor (SLPI) does not modulate experimental osteoarthritis but may be a biomarker for the disease.
    Kim HE; Shin Y; Jung IJ; Yang JI; Chun CH; Kim HA; Chun JS
    Osteoarthritis Cartilage; 2021 Apr; 29(4):558-567. PubMed ID: 33485930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.